Tigecycline application in a 3-month-old infant with multiple drug resistant Klebsiella pneumonia: a case report

Tigecycline application in a 3-month-old infant with multiple drug resistant Klebsiella pneumonia: a case report

Abstract Background Tigecycline is an ‘immature’ antibiotic for children. We report the youngest surviving patient who received a complete tigecycline treatment, and no significant adverse effects occurred in the patient. Case presentation The 3-month old infant suffered from a catheter-associated b...

Full description

Bibliographic Details
Main Authors:	Cheng Peng, Xiaofeng Wang, Jiangwei Zhang, Yi Jiang, Xinlin Hou
Format:	Article
Language:	English
Published:	BMC 2018-06-01
Series:	Gut Pathogens
Subjects:	Multiple drug resistant Klebsiella pneumoniae Tigecycline Pediatric
Online Access:	http://link.springer.com/article/10.1186/s13099-018-0253-x

Similar Items

Tigecycline-amikacin combination effectively suppresses the selection of resistance in clinical isolates of KPC-producing Klebsiella pneumoniae
by: Wentao Ni, et al.
Published: (2016-08-01)

Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant <i>Klebsiella pneumoniae</i> Pneumonia–Septicemia Model in Rats
by: Hessel Van der Weide, et al.
Published: (2020-03-01)

Effect of ramR loss-of-function insertion on tigecycline resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae
by: Yihan Mao, et al.
Published: (2020-06-01)

Characterization of Tigecycline-Heteroresistant Klebsiella pneumoniae Clinical Isolates From a Chinese Tertiary Care Teaching Hospital
by: Qiaoyu Zhang, et al.
Published: (2021-08-01)

Carbapenemase-producing Klebsiella pneumoniae intra-abdominal infection successfully treated with ceftazidime/avibactam plus tigecycline
by: Mariana Guedes, et al.
Published: (2020-01-01)

The Plasmid-Borne tet(A) Gene Is an Important Factor Causing Tigecycline Resistance in ST11 Carbapenem-Resistant Klebsiella pneumoniae Under Selective Pressure
by: Juan Xu, et al.
Published: (2021-02-01)

Change of Hypermucoviscosity in the Development of Tigecycline Resistance in Hypervirulent <i>Klebsiella pneumoniae</i> Sequence Type 23 Strains
by: Suyeon Park, et al.
Published: (2020-10-01)

The Rapid Emergence of Tigecycline Resistance in blaKPC–2 Harboring Klebsiella pneumoniae, as Mediated in Vivo by Mutation in tetA During Tigecycline Treatment
by: Xiaoxing Du, et al.
Published: (2018-04-01)

Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae
by: Yin Yuhan, et al.
Published: (2016-04-01)

Molecular Analysis and Antimicrobial Resistance Pattern of Tigecycline-Non-Susceptible K. pneumoniae Isolated from a Tertiary Care Hospital of East Asia
by: Hu N, et al.
Published: (2021-10-01)

A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infections: tigecycline significantly increases the mortality
by: Xiao T, et al.
Published: (2018-04-01)

In vivo Emergence of Colistin and Tigecycline Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae During Antibiotics Treatment
by: Jiawei Chen, et al.
Published: (2021-09-01)

Characterization of Tigecycline Resistance Among Tigecycline Non-susceptible Klebsiella pneumoniae Isolates From Humans, Food-Producing Animals, and in vitro Selection Assay
by: Mohaddeseh Moghimi, et al.
Published: (2021-08-01)

CusS-CusR Two-Component System Mediates Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae
by: Dongjie Chen, et al.
Published: (2020-01-01)

Tigecycline and Community-Acquired Pneumonia
by: Sercan ULUSOY
Published: (2013-12-01)

Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia
by: Jiawei Zeng, et al.
Published: (2017-08-01)

Emergence of NDM-5-Producing Carbapenem-Resistant Klebsiella pneumoniae and SIM-Producing Hypervirulent Klebsiella pneumoniae Isolated from Aseptic Body Fluid in a Large Tertiary Hospital, 2017–2018: Genetic Traits of blaNDM-Like and blaSIM-Like Genes as Determined by NGS
by: Li Q, et al.
Published: (2020-09-01)

Treatment of <it>Klebsiella Pneumoniae</it> Carbapenemase (KPC) infections: a review of published case series and case reports
by: Lee Grace C, et al.
Published: (2012-12-01)

Treatment Options for Colistin Resistant <i>Klebsiella pneumoniae</i>: Present and Future
by: Nicola Petrosillo, et al.
Published: (2019-06-01)

Molecular Characterization of an IncFIIk Plasmid Co-harboring blaIMP–26 and tet(A) Variant in a Clinical Klebsiella pneumoniae Isolate
by: Hong Yao, et al.
Published: (2020-07-01)

Extensively drug-resistant Klebsiella pneumoniae pneumonia: A case report
by: Saurabh Karmakar, et al.
Published: (2020-01-01)

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
by: Sheng-Huei Wang, et al.
Published: (2021-09-01)

ANTIBIOTIC RESISTANCE OF KLEBSIELLA PNEUMONIAE TO CEPHALOSPORINS
by: E. V. Anganova, et al.
Published: (2017-07-01)

Acquisition of Tigecycline Resistance by Carbapenem-Resistant Klebsiella pneumoniae Confers Collateral Hypersensitivity to Aminoglycosides
by: Hua-le Chen, et al.
Published: (2021-07-01)

Carbapenem Resistance Pattern of Multiple Drug-Resistantand Extended-Spectrum Beta-Lactamase-Positive Klebsiella pneumonia in Isfahan
by: Hossein Fazeli, et al.
Published: (2014-11-01)

Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
by: Yangang Zhou, et al.
Published: (2019-04-01)

Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection
by: Shujuan Ji, et al.
Published: (2015-09-01)

Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
by: Jeffrey Baron, et al.
Published: (2018-03-01)

Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST)
by: Zhang Z, et al.
Published: (2019-05-01)

Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry
by: Daniel Curcio, et al.

Typization of Klebsiella pneumoniae strains collected from a immature pediatric ward by Mass Spectrometry using MALDI-TOF
by: Roberto Degl’Innocenti, et al.
Published: (2011-12-01)

A 5 year (2005-2009) review of antimicrobial susceptibility of clinical Klebsiella pneumoniae isolates from pediatric patients in Jordan
by: Mohammad Al-Shara
Published: (2013-10-01)

Long-term, low-dose tigecycline to treat relapsing bloodstream infection due to KPC-producing Klebsiella pneumoniae after major hepatic surgery
by: Luca Morelli, et al.
Published: (2015-07-01)

NEUMONÍA POR KLEBSIELLA PNEUMONIAE EN PACIENTE CON INFARTO AGUDO DE MIOCARDIO / Klebsiella pneumoniae pneumonia in a patient with acute myocardial infarction
by: Ana M. Jeréz Castro, et al.
Published: (2012-03-01)

Klebsiella pneumoniae Antimicrobial Drug Resistance, United States, 1998–2010
by: Guillermo V. Sanchez, et al.
Published: (2013-01-01)

Risk factors for KPC-producing Klebsiella pneumoniae bacteremia
by: Felipe F. Tuon, et al.

KPC-producing Klebsiella pneumoniae, finally targeting Turkey
by: J. Labarca, et al.
Published: (2014-03-01)

In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia
by: Peter J. Petersen, et al.
Published: (2010-02-01)

Evaluation of Antimicrobial Resistance Rates in Klebsiella Isolates
by: Selçuk NAZİK, et al.
Published: (2018-12-01)

Carbapenemase-producing Klebsiella pneumoniae and Hematologic Malignancies
by: Livio Pagano, et al.
Published: (2014-07-01)